Preferred Label : talimogene laherparepvec;

MeSH synonym : T-VEC;

Details


Main resources

You can consult :


https://www.ema.europa.eu/medicines/human/EPAR/Imlygic
2016
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Talimogene Laherparepvec
Talimogene Laherparepvec
drug approval
europe
drug interactions
pregnancy
breast feeding
adult
antineoplastic agents
antineoplastic agents
gene therapy
melanoma
neoplasm metastasis
Stage IV Cutaneous Melanoma AJCC v6 and v7
melanoma, cutaneous malignant
Unresectable Malignant Neoplasm
oncolytic viruses
oncolytic viruses
injections, intralesional
herpesvirus 1, human
adjuvants, immunologic
adjuvants, immunologic
drug monitoring
product surveillance, postmarketing
contraception
drug evaluation, preclinical
drug storage
talimogene laherparepvec
genetic therapy
talimogene laherparepvec
talimogene laherparepvec
biological products
biological products

---
Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.